A study of US Medicare Part D prescription drug benefit users has found that only 5% are likely to switch providers, with 29% who are uncertain. Overall, the survey finds that seniors enrolled on the Part D program, which launched last year (Marketletters passim), are satisfied with the services they receive, although many believe it is "too complicated." The survey was carried out by the Kaiser Family Foundation and the Harvard School of Public Health.
For the US federal government, there is the satisfaction of the study's finding that 76% of Part D enrollees described their experience of the scheme as "positive," with almost half (46%) claiming to have a "very positive" opinion of the Medicare drug benefit.
Rx benefit becoming more popular
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze